Senseonics (NYSE:SENS) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Senseonics (NYSE:SENS) in a research report released on Sunday morning. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright restated a “buy” rating and issued a $2.00 target price on shares of Senseonics in a report on Friday, November 15th.

Senseonics Trading Down 2.1 %

Shares of Senseonics stock opened at $0.32 on Friday. The company has a fifty day simple moving average of $0.34 and a 200-day simple moving average of $0.39. Senseonics has a 12-month low of $0.28 and a 12-month high of $0.75. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. FMR LLC boosted its holdings in shares of Senseonics by 48,267.2% in the 3rd quarter. FMR LLC now owns 168,318 shares of the company’s stock valued at $59,000 after buying an additional 167,970 shares in the last quarter. State Board of Administration of Florida Retirement System purchased a new stake in shares of Senseonics in the first quarter valued at about $91,000. GSA Capital Partners LLP acquired a new stake in shares of Senseonics during the third quarter worth about $117,000. Virtu Financial LLC purchased a new position in shares of Senseonics during the first quarter worth about $162,000. Finally, Symmetry Partners LLC acquired a new position in Senseonics in the 3rd quarter valued at about $164,000. Institutional investors and hedge funds own 12.36% of the company’s stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.